EUVIMEDOpdag EUVIMED
Open access

Exploring Opportunities and Challenges for the Spread, Scale-Up, and Sustainability of mHealth Apps for Self-Management of Patients With Type 2 Diabetes Mellitus in the Netherlands: Citizen Science Approach

Chancen und Herausforderungen für Verbreitung, Skalierung und Nachhaltigkeit von mHealth-Apps zur Selbstmanagement-Unterstützung von Patient:innen mit Typ-2-Diabetes in den Niederlanden: Citizen-Science-Ansatz

Catharina Margaretha van Leersum iD, Marloes Bults iD, Egbert Siebrand iD, Theodorus Johannes Josef Olthuis iD, Robin Enya Marije Bekhuis iD, Annemieke Ariënne Johanneke Konijnendijk iD, Marjolein Elisabeth Maria den Ouden iD

JMIR Diabetes · 2024-12-17 · 9 · e56917

DOI: 10.2196/56917 ↗

Auf einen Blick

Die Studie untersuchte Herausforderungen bei der Implementierung von mHealth-Apps für Patient:innen mit Typ-2-Diabetes. Genannt wurden Hürden und fördernde Faktoren in mehreren NASSS-Domänen.

Fragestellung

Welche Herausforderungen der Implementierung von mHealth-Apps bei Typ-2-Diabetes erschweren Verbreitung, Skalierung und Nachhaltigkeit?

Methode

NASSS-Framework; Citizen-Science-Ansatz mit Fragebögen, semistrukturierten Interviews und Fokusgruppen mit Patient:innen, Fachpersonen, Entwickler:innen, Policy-Officers und einer Patientenorganisation.

Ergebnisse

In den NASSS-Domänen wurden Bewusstsein für die Erkrankung, Lebensstiländerung, rasche App-Entwicklung, Nutzerwissen, personalisierte Versorgung, Verantwortlichkeiten, gemeinsame Vision, Widerstand von Fachpersonen sowie Einbindung von Institutionen, Leitlinien und Erstattung genannt.

Einschränkungen

Die Implementierung wurde in einem frühen Stadium untersucht.

Schlussfolgerung der Autor:innen

Die Studie zeigte Möglichkeiten und Grenzen der Implementierung von mHealth-Apps früh im Prozess. Wichtig sind eine klare organisatorische Vision und spezifische Voraussetzungen für Strategien auf Mikro-, Meso- und Makroebene.

Kernaussagen

  • NASSS-Domänen strukturierten die Analyse der Implementierung
  • Zentrale Themen waren Nutzerwissen, Organisation und Widerstand
  • Nationale Strategien betreffen Regulierung, Leitlinien und Erstattung

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Journal article in JMIR Diabetes, published online on 2024-12-17. Written by Catharina Margaretha van Leersum and 6 co-authors. Institution: Department of Technology, Policy, and Society, Faculty of Behavioural, Management, and Social Sciences, University of Twente, Enschede, Netherlands. Cited 8 times so far (Crossref); 25 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Technologies evolve at a breakneck pace, and the success of mobile health (mHealth) for people with type 2 diabetes mellitus (T2DM) depends on whether health care professionals, care management, government regulators, and consumers will adopt the technology as a viable solution to enhance patient self-management.

Objective

In this study, we explored the challenges of the implementation of mHealth apps in care for patients with T2DM and determined to what extent these challenges complicate the dissemination, limit scale-up, and influence the sustainability of technological interventions for patients with T2DM.

Methods

The nonadoption, abandonment, and challenges to scale-up, spread, and sustainability (NASSS) framework served as the basis for our study. The 7 domains of the NASSS framework were explored with a citizen science approach using questionnaires, semistructured in-depth interviews, and focus groups together with patients with T2DM, care professionals, technology developers, policy officers, and a patient organization.

Results

Regarding the domain “condition,” being aware of their condition and changing lifestyle were crucial for patients with T2DM to get to grips with their life. The rapid development of health apps for T2DM was highlighted in the domain “technology.” Users should be aware of these apps and know how to use them. The domain “value proposition” included the patient perspective and elaborated on personal values, as well as care professionals who focus on personalized care and pressure on health care. Regarding the “adopters,” it is crucial to know who needs to use and introduce the apps. Responsibility, a shared vision, and resistance among care professionals were mentioned as important determinants for “organization.” Finally, the domain “wider system” showed the importance of involving multiple institutes, care guidelines, and reimbursements.

Conclusions

This study investigated the implementation of mHealth apps in an early stage of the implementation process. Key stakeholders were involved, who attributed to the possibilities and limitations of the implementation. It is crucial to have a clear vision from an organizational perspective and specific prerequisites for implementation strategies at micro, meso, and macro levels. Essential strategies at the national level include guidelines for regulations, privacy, and security; the integration of mHealth into T2DM care guidelines; and sufficient reimbursement by health insurers.

Subjects

Author keywords

DMcitizen sciencediabetesdigital healthdigital interventiondigital technologyhealth care systemimplementationmHealthmobile appmobile healthself-managementsmartphonetype 1 diabetestype 2 diabetes

Authors and institutions

  • Department of Technology, Policy, and Society, Faculty of Behavioural, Management, and Social Sciences, University of Twente, Enschede, Netherlands.
  • Faculty of Humanities, Open Universiteit, Heerlen, Netherlands.
  • Technology, Health & Care Research Group, Saxion University of Applied Sciences, Enschede, Netherlands.
  • Ethics and Technology Research Group, Saxion University of Applied Sciences, Deventer, Netherlands.
  • Care & Technology Research Group, Regional Community College of Twente, Hengelo, Netherlands.
  • Department of Smartup Innovation, Ziekenhuisgroep Twente, Almelo, Netherlands.

ORCID profiles: Catharina Margaretha van Leersum, Marloes Bults, Egbert Siebrand, Theodorus Johannes Josef Olthuis, Robin Enya Marije Bekhuis, Annemieke Ariënne Johanneke Konijnendijk, Marjolein Elisabeth Maria den Ouden

Cite

APA

van Leersum, C. M., Bults, M., Siebrand, E., Olthuis, T. J. J., Bekhuis, R. E. M., Konijnendijk, A. A. J., & den Ouden, M. E. M. (2024). Exploring Opportunities and Challenges for the Spread, Scale-Up, and Sustainability of mHealth Apps for Self-Management of Patients With Type 2 Diabetes Mellitus in the Netherlands: Citizen Science Approach. JMIR Diabetes, 9, e56917. https://doi.org/10.2196/56917

Vancouver

van Leersum CM, Bults M, Siebrand E, Olthuis TJJ, Bekhuis REM, Konijnendijk AAJ, et al. Exploring Opportunities and Challenges for the Spread, Scale-Up, and Sustainability of mHealth Apps for Self-Management of Patients With Type 2 Diabetes Mellitus in the Netherlands: Citizen Science Approach. JMIR Diabetes. 2024;9:e56917. doi:10.2196/56917

BibTeX
@article{vanLeersum2024,
  author = {van Leersum, Catharina Margaretha and Bults, Marloes and Siebrand, Egbert and Olthuis, Theodorus Johannes Josef and Bekhuis, Robin Enya Marije and Konijnendijk, Annemieke Ariënne Johanneke and den Ouden, Marjolein Elisabeth Maria},
  title = {Exploring Opportunities and Challenges for the Spread, Scale-Up, and Sustainability of mHealth Apps for Self-Management of Patients With Type 2 Diabetes Mellitus in the Netherlands: Citizen Science Approach},
  journal = {JMIR Diabetes},
  year = {2024},
  volume = {9},
  pages = {e56917},
  doi = {10.2196/56917}
}
Start for free →